$43.4B
$853,000
0.0% of portfolio
4,791
Q3 2024
Added 44.05%
$1.01B
$738,000
0.0% of portfolio
19,100
Q3 2024
Reduced 6.37%
$864M
$529,000
0.0% of portfolio
86,600
Q1 2024
Reduced 5.97%
$467M
$1.03 Million
0.0% of portfolio
56,527
Q3 2024
Reduced 51.03%
$140M
$32,000
0.0% of portfolio
17,900
Q1 2024
Reduced 5.79%
$2.61B
$433,000
0.0% of portfolio
70,900
Q3 2024
Added 3.96%
-
$0
0.0% of portfolio
-
Q3 2024
New
$1.06B
$661,000
0.0% of portfolio
26,400
Q3 2024
Reduced 18.52%
$502M
$162,000
0.0% of portfolio
6,900
Q2 2024
Added 666.67%
$4.33B
$827,000
0.0% of portfolio
7,900
Q3 2024
Reduced 8.14%
$3.65B
$104,000
0.0% of portfolio
1,500
Q3 2024
Reduced 88.46%
Contineum Therapeutics Inc A
-
$0
0.0% of portfolio
-
Q2 2024
New
$2.71B
$508,000
0.0% of portfolio
21,100
Q3 2024
Reduced 85.99%
$862M
$531,000
0.0% of portfolio
33,000
Q2 2024
Added 63.37%
$1.01B
$487,000
0.0% of portfolio
61,400
Q2 2024
Added 11.43%
$700M
$528,000
0.0% of portfolio
10,000
Q3 2024
New
$223M
$310,000
0.0% of portfolio
44,800
Q3 2024
Reduced 47.04%
$2.94B
$240,000
0.0% of portfolio
4,700
Q3 2024
Reduced 33.8%
$836M
$438,000
0.0% of portfolio
26,300
Q2 2024
Added 11.44%
$367M
$74,000
0.0% of portfolio
3,900
Q1 2024
Reduced 7.14%
$4.73B
$623,000
0.0% of portfolio
11,800
Q3 2024
Reduced 4.07%
$801M
$145,000
0.0% of portfolio
26,200
Q3 2024
New
$157M
$112,000
0.0% of portfolio
8,700
Q3 2024
Added 45.0%
$1.32B
$292,000
0.0% of portfolio
15,600
Q3 2024
Reduced 38.82%
$3.36B
$506,000
0.0% of portfolio
17,400
Q2 2024
Added 33.85%
$324M
$175,000
0.0% of portfolio
32,600
Q2 2024
Added 11.26%
$515M
$581,000
0.0% of portfolio
3,600
Q3 2024
Reduced 2.7%
$0
$0
0.0% of portfolio
58,268
Q3 2024
New
$129M
$46,000
0.0% of portfolio
15,200
Q1 2024
Reduced 6.17%
-
$0
0.0% of portfolio
-
Q3 2024
Added 2.41%
$107M
$132,000
0.0% of portfolio
14,200
Q3 2024
Added 56.04%
$36.7B
$932,000
0.0% of portfolio
8,103
Q3 2024
Added 5.85%
$603M
$179,000
0.0% of portfolio
42,800
Q1 2024
Reduced 14.4%
$1.79B
$72,000
0.0% of portfolio
1,100
Q3 2024
Reduced 89.81%
$3.23B
$530,000
0.0% of portfolio
30,200
Q2 2024
Added 4.5%
$553M
$177,000
0.0% of portfolio
13,900
Q3 2024
Added 16.81%
$1.47B
$380,000
0.0% of portfolio
10,600
Q2 2024
Reduced 48.04%
$910M
$43,000
0.0% of portfolio
1,200
Q3 2024
New
$5.46B
$1 Million
0.0% of portfolio
23,064
Q3 2024
Reduced 18.57%
$1.1B
$247,000
0.0% of portfolio
18,200
Q2 2024
Added 5.81%
$3.28B
$99,000
0.0% of portfolio
6,100
Q3 2024
New
$1.12B
$2,000
0.0% of portfolio
400
Q1 2023
Reduced 89.19%
$1.99B
$250,000
0.0% of portfolio
9,400
Q3 2024
Reduced 36.49%
$167M
$263,000
0.0% of portfolio
51,600
Q2 2024
Added 11.45%
$12.3M
$5,000
0.0% of portfolio
9,700
Q2 2024
New
$109M
$26,000
0.0% of portfolio
5,300
Q2 2024
New
$731M
$198,000
0.0% of portfolio
15,400
Q2 2024
Added 14.07%
$5.54B
$693,000
0.0% of portfolio
19,100
Q3 2024
Reduced 5.45%
$198M
$125,000
0.0% of portfolio
12,100
Q2 2024
Reduced 24.38%
$3.91B
$306,000
0.0% of portfolio
3,000
Q2 2024
Reduced 64.71%